Barinthus Biotherapeutics PLC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
International Generosity Foundation Trust reports beneficial ownership of 2,734,189 shares, representing 6.7% of Barinthus Biotherapeutics plc's common stock, acquired for investment and charitable purposes.